Evidence map›Paper›PMID 30816324›Full record

ArticleScientific reports2019

Treatment with maresin 1, a docosahexaenoic acid-derived pro-resolution lipid, protects skin from inflammation and oxidative stress caused by UVB irradiation.

Talita L C Cezar, Renata M Martinez, Camila da Rocha, Cristina P B Melo, David L Vale, Sergio M Borghi, Victor Fattori, Josiane A Vignoli, Doumit Camilios-Neto, Marcela M Baracat and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Uncovering a photoprotective polysaccharide fromPharmaceutical science advances · 2026
    Article
  3. Dirhamnolipids fromACS omega · 2026
    Article
  4. Article
  5. Review
  6. Comparative Efficacy ofMolecules (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Talita L C CezarLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Renata M MartinezLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Camila da RochaLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Cristina P B MeloLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
David L ValeLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Sergio M BorghiLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, PR, Brazil.
Victor FattoriLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, PR, Brazil.
Josiane A VignoliDepartment of Biochemistry and Biotechnology, Londrina State University, Londrina, PR, Brazil.
Doumit Camilios-NetoDepartment of Biochemistry and Biotechnology, Londrina State University, Londrina, PR, Brazil.ORCID 0000-0002-1986-658X
Marcela M BaracatLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Sandra R GeorgettiLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil.
Waldiceu A VerriLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, PR, Brazil.ORCID 0000-0003-2756-9283
Rubia CasagrandeLaboratory of Oxidative Stress and Inflammation, Department of Pharmaceutical Sciences, Londrina State University, Londrina, PR, Brazil. rubiacasa@yahoo.com.br.
Universidade Estadual de Londrina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute exposure to UVB irradiation causes skin inflammation and oxidative stress, and long-term exposure to UVB irradiation may lead to carcinogenesis. Our organism has endogenous mechanisms to actively limit inflammation. Maresin 1 (MaR1; 7R,14S-dihydroxy-docosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid) is a pro-resolution lipid mediator derived from the docosahexaenoic acid, which presents anti-inflammatory and pro-resolution effects. However, it remains to be determined if treatment with MaR1 can inhibit inflammatory and oxidative alterations in the skin triggered by UVB. The treatment with MaR1 (0.1-10 ng/mice at -10 min relative to the UVB irradiation protocol) reduced UVB-induced skin edema, neutrophil recruitment (MPO; myeloperoxidase activity, and migration of LysM-eGFP

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsDocosahexaenoic AcidsInflammationMiceMice, HairlessMice, Inbred C57BLOxidative StressSkinUltraviolet Rays7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acidAnti-Inflammatory AgentsAntioxidantsDocosahexaenoic Acids

Identifiers

PMID30816324
PMCPMC6395735
OpenAlexW2917891702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.